IB Acquisition Corp(IBAC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.09 | Insider Own | 76.96% | Shs Outstand | 5.0M | Perf Week | 0.28% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | -8.1% | Shs Float | 1.1M | Perf Month | 1.02% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | - | Inst Own | 9.39% | Short Float | 0.05% | Perf Quarter | 1.11% |
| Income | -0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.22 | Perf Half Y | 1.68% |
| Sales | 0.00B | P/B | 9.01 | EPS next 5Y | - | ROA | -0.61% | Short Interest | 0.00M | Perf YTD | 4% |
| Book/sh | 1.21 | P/C | 1823 | EPS past 3/5Y | - | ROE | -0.63% | 52W High | -4.63% ($11.45) | Perf Year | 3.21% |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | -6.58% | 52W Low | 7.16% ($10.19) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -137.33% | Gross Margin | - | Volatility(W/M) | 0.41% 0.37% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.1 | EPS Q/Q | -317.69% | Profit Margin | - | RSI (14) | 69.87 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.1 | Sales Q/Q | - | SMA20 | 0.51% ($10.86) | Beta | 0 | Target Price | - |
| Payout | - | Debt/Eq | 0.08 | Earnings | - | SMA50 | 0.99% ($10.81) | Rel Volume | 0 | Prev Close | $10.92 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 2.55% ($10.65) | Avg Volume(3M) | 0.00M | Price | $10.92 |
| IPO | 2024/5/1 | Option/Short | No/Yes | Trades | 1 | Volume | 7 | Change | - |
Company
IBAC is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A special purpose acquisition company (SPAC) that aims to drive innovation in the biotech market by merging with GNQ Insilico, an AI-powered drug discovery platform company.
Over the past 1 year, roughly in the middle
5% below its 1-year high.
IBAC has weak earning power
Review management risk carefully before investing
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 9.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SPAX 0.03%
RNMN 0.00%
SPCZ 0.00%It ranks #4 in the industry
Based on market cap of $55M.
IBAC $55M PER -
LION $3B PER -
BBCQ $2B PER -
CCXI $686M PER -
FAQ
What kind of company is IBAC?
IBAC belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of IBAC?
The market cap of IBAC is approximately $55M, ranking 4,908 within its sector.
What is the 52-week high and low for IBAC?
IBAC has recorded a 52-week high of $11.45 and a low of $10.19.
